Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102460431 | 10246043 | 1 | I | 20130415 | 20130515 | 20130531 | 20130531 | EXP | 2013-0685 | ONYX | 73.00 | YR | F | N | 63.00000 | KG | 20130529 | N | MD | CZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102460431 | 10246043 | 1 | PS | CARFILZOMIB (CARFILZOMIB) (20 MILLIGRAM(S)/SQ.METER, INJECTION FOR INFUSION) (CARFILZOMIB) | 1 | INTRAVENOUS | 9.4286 MG (33 MG, DAYS 1, 2) | D | D | 202714 | |||||||||
| 102460431 | 10246043 | 2 | SS | LENALIDOMIDE | 1 | ORAL | 18.75 MG (33, 25 MG DAY 1-21, EVERY 28 DAYS) | Y | D | 0 | |||||||||
| 102460431 | 10246043 | 3 | SS | DEXAMETHASONE (DEXAMETHASONE) | 1 | 5.7143 MG (40 MG DAYS 1,8,15,22, EVERY DAYS) | Y | D | 0 | ||||||||||
| 102460431 | 10246043 | 5 | C | ASPIRIN (ACETYLSALICYLIC ACID) | 1 | 0 | |||||||||||||
| 102460431 | 10246043 | 7 | C | ENTIZOL (IMETRONIDAZOLE) | 2 | 0 | |||||||||||||
| 102460431 | 10246043 | 9 | C | HERPESIN (ACICLOVIR) | 2 | 0 | |||||||||||||
| 102460431 | 10246043 | 11 | C | KALIUM CHLORATUM 7.5% (POTASSIUM CHLORIDE) | 2 | 0 | |||||||||||||
| 102460431 | 10246043 | 13 | C | LANSOPROL (LANSOPRAZOLE) | 2 | 0 | |||||||||||||
| 102460431 | 10246043 | 15 | C | LODRONAT (CLODRONATE DISODIUM) | 2 | 0 | |||||||||||||
| 102460431 | 10246043 | 17 | C | PANZYTRAT (PANCRATIN) | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102460431 | 10246043 | 1 | Plasma cell myeloma |
| 102460431 | 10246043 | 2 | Plasma cell myeloma |
| 102460431 | 10246043 | 3 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102460431 | 10246043 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102460431 | 10246043 | Confusional state | |
| 102460431 | 10246043 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 102460431 | 10246043 | SDY |
| 102460431 | 10246043 | HP |
| 102460431 | 10246043 | FGN |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102460431 | 10246043 | 1 | 20110822 | 20110823 | 0 | |
| 102460431 | 10246043 | 1 | 20110829 | 20110906 | 0 | |
| 102460431 | 10246043 | 1 | 20110919 | 20120117 | 0 | |
| 102460431 | 10246043 | 1 | 20120206 | 20120710 | 0 | |
| 102460431 | 10246043 | 1 | 20120723 | 20120724 | 0 | |
| 102460431 | 10246043 | 1 | 20120820 | 20121228 | 0 | |
| 102460431 | 10246043 | 2 | 20110822 | 20120122 | 0 | |
| 102460431 | 10246043 | 2 | 20120206 | 20120805 | 0 | |
| 102460431 | 10246043 | 2 | 20120820 | 20130317 | 0 | |
| 102460431 | 10246043 | 3 | 20110822 | 20120116 | 0 | |
| 102460431 | 10246043 | 3 | 20120206 | 20120806 | 0 | |
| 102460431 | 10246043 | 3 | 20120820 | 20130318 | 0 |